Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Swab Sampling for Cleaning Validation – V 2.0

Posted on By

Elixir Department: SOP for Swab Sampling for Cleaning Validation – V 2.0

Standard Operating Procedure for Swab Sampling for Cleaning Validation in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/174/2025
Supersedes SOP/ELX/174/2022
Page No. Page 1 of 10
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a standardized procedure for performing swab sampling for cleaning validation in the Elixir Department to verify the absence of product residues, cleaning agents, and microbial contamination on product-contact surfaces.

2. Scope

This SOP applies to all cleaned equipment, utensils, and contact surfaces used in elixir manufacturing where swab sampling is required as part of cleaning validation or verification process.

3. Responsibilities

  • QA Personnel:
    • Perform swab sampling after cleaning and prior to equipment reuse.
    • Ensure sampling is performed in accordance with the validation protocol.
  • QC Personnel:
    • Analyze swab samples for chemical, microbiological, or detergent residues.
  • Production Department:
    • Ensure equipment remains in “Hold” status until approved for reuse.
See also  Elixir Department: SOP for Weight Verification Before Final Transfer - V 2.0

4. Accountability

The QA Head is accountable for sampling integrity and documentation. The QC Head ensures timely testing and accurate reporting. The Production Head ensures cleaning is completed before sampling.

5. Procedure

5.1 Sampling Material and Area Selection

  1. Use sterile, pre-moistened swabs (with purified water or neutralizing agent as per protocol).
  2. Select worst-case and difficult-to-clean locations for sampling such as:
    • Tank corners
    • Outlet valves
    • Agitator shafts
    • Gasket grooves
  3. Use a template of 10 cm × 10 cm (100 cm²) or as specified to define the swab area.

5.2 Swabbing Technique

  1. Wipe the defined area horizontally using one side of the swab.
  2. Flip the swab and wipe vertically on the same area.
  3. Repeat for a second location using a new sterile swab if multiple samples are needed.
  4. Place the swab in a labeled sterile container (e.g., test tube with transport medium or dry vial).
See also  Elixir Department: SOP for pH Testing of Final Product - V 2.0

5.3 Labeling and Transportation

  1. Label each container with:
    • Sample ID
    • Date and time
    • Equipment name/ID
    • Swab location
    • Cleaned by / Swabbed by
  2. Transport the samples to QC lab within 30 minutes. If delayed, store at 2–8°C (for microbiological analysis).

5.4 Testing and Results

  1. QC will analyze swabs for:
    • API or excipient residues (e.g., via HPLC, UV)
    • Detergent residues (e.g., via TOC, conductivity)
    • Microbial load (TVC and objectionable organisms)
  2. Compare results with acceptance limits defined in cleaning validation protocols.
  3. Document results and share with QA for equipment release decision.

5.5 Documentation

  1. Record swab sample details in the Swab Sampling Logbook (Annexure-1).
  2. QC to document results in the Cleaning Validation Test Report.
  3. QA to issue clearance or request re-cleaning if results exceed limits.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • TOC: Total Organic Carbon
  • TVC: Total Viable Count
See also  Elixir Department: SOP for Environmental Conditions for Dispensing of Elixirs - V 2.0

7. Documents

  1. Swab Sampling Logbook (Annexure-1)
  2. Cleaning Validation Protocol
  3. Cleaning Validation Test Report

8. References

  • 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
  • ICH Q7 – GMP for APIs
  • WHO TRS 937 – Annex 4: Cleaning Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Swab Sampling Logbook

Date Equipment ID Swab Location Sample ID Swabbed By Sent to QC QC Result QA Decision
11/04/2025 MXR-ELX-11 Bottom Valve SS-ELX-20250411-01 Rajesh Kumar Yes Compliant Approved

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Aligned with updated validation protocol and added TOC/microbial scope Audit Compliance QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Gel Manufacturing: SOP for In-process Sampling and Testing during Gel Manufacturing – V 2.0
Next Post: Quality Control: SOP for Analyzing Residual Solvents in Injectable Formulations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version